nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy
|
Peper, Janet Kerstin |
|
2015 |
64 |
10 |
p. 1295-1303 |
artikel |
2 |
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
|
Krishnadas, Deepa K. |
|
|
64 |
10 |
p. 1251-1260 |
artikel |
3 |
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
|
Krishnadas, Deepa K. |
|
2015 |
64 |
10 |
p. 1251-1260 |
artikel |
4 |
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
|
Sersa, Gregor |
|
2015 |
64 |
10 |
p. 1315-1327 |
artikel |
5 |
Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer
|
Scrimini, Sergio |
|
2015 |
64 |
10 |
p. 1261-1270 |
artikel |
6 |
Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
|
Venuti, Aldo |
|
2015 |
64 |
10 |
p. 1329-1338 |
artikel |
7 |
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
|
Santegoets, Saskia J. A. M. |
|
2015 |
64 |
10 |
p. 1271-1286 |
artikel |
8 |
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
|
Tagliamonte, Maria |
|
2015 |
64 |
10 |
p. 1305-1314 |
artikel |
9 |
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
|
Tagliamonte, Maria |
|
|
64 |
10 |
p. 1305-1314 |
artikel |
10 |
Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells
|
Ostrand-Rosenberg, Suzanne |
|
2015 |
64 |
10 |
p. 1287-1293 |
artikel |
11 |
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma
|
Guislain, Aurelie |
|
|
64 |
10 |
p. 1241-1250 |
artikel |
12 |
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma
|
Guislain, Aurelie |
|
2015 |
64 |
10 |
p. 1241-1250 |
artikel |
13 |
Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice
|
Stermann, Alexander |
|
2015 |
64 |
10 |
p. 1215-1227 |
artikel |
14 |
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines
|
Ugel, Stefano |
|
2015 |
64 |
10 |
p. 1339-1348 |
artikel |
15 |
The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24–26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy
|
Signori, Emanuela |
|
2015 |
64 |
10 |
p. 1349-1356 |
artikel |
16 |
TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice
|
Koga-Yamakawa, Erina |
|
2015 |
64 |
10 |
p. 1229-1239 |
artikel |